Abstract
BackgroundTreatment cessation in chronic HBV infection may be durable in certain patient subgroups before hepatitis B surface antigen (HBsAg) seroclearance. The role of serum HBV RNA in determining treatment cessation...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have